The Borgen Project recently blogged about Britain's large drug company, GlaxoSmithKline, doing good deeds like lifting patent restrictions on HIV advancements. Well, they're at it again. Now, GSK recently released the details of 13,500 chemical compounds that have the ability to fight Malaria in developing countries. Slowly but surely we are seeing an increase in idea-sharing and product synergy in medicine like never before. Hopefully, with efforts from those like GSK, we can develop better medicine faster with world-wide availability.
-Nick Mohazzabfar
Posts
